Jackson Walker advised Kamada Ltd. in acquiring the assets of Blood and Plasma Research, Inc. (B&PR), an FDA-licensed plasma collection center focused on collecting hyperimmune plasma, through its subsidiary Kamada Plasma LLC.
Founded in Israel in 1990, Kamada Ltd. concentrates on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline.
Located in Beaumont, Texas, the B&PR collection facility primarily specialized in the collection of hyper-immune plasma used for the Anti-D immunoglobulin, which is manufactured by Kamada and distributed in international markets. B&PR is one of only a few collection centers in the United States that provide the raw material needed to make these products.
With the acquisition, Kamada enters the U.S. plasma collection market and advances its strategic goal to become a fully integrated specialty plasma company.
Kamada CEO Amir London said in a company statement, “We plan to significantly expand our hyperimmune plasma collection capacity by investing in B&PR’s center at Beaumont, Texas, and leveraging its FDA license to open additional centers in the U.S.”
For additional information about the transaction, view Kamada’s news release and fourth quarter and fiscal 2020 financial results announcement.
In addition to Marisela Gonzalez and Virginia Mimmack, the Jackson Walker team also included Jamila Brinson, Chuck Campbell, Jeff Drummond, John Ransom, Pete Wahl, Alyca Riley Garrison, Ebony Harris, Taylor McDowell, and Eve Searls.
Founded in 1887, Jackson Walker continues to advance the world of business by helping companies of all sizes navigate today’s increasingly complex, interconnected legal landscape. With more than 400 attorneys across seven offices, we are the third-largest law firm in the state and have been recognized by Law360 as a “Texas Powerhouse” and an “elite law firm” that regularly provides counsel to industry-leading clients on highly complex transactions. To explore the Firm’s experience advising healthcare clients in mergers, acquisitions, dispositions, joint ventures, and other strategic alliances, visit our Healthcare and Corporate & Securities practice pages.